ConductScience.org, home

Paper405385

Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol.

Abuchowski A and 3 others. J Biol Chem, 1977. Cited by 779 papers, by iCite.

Cite this record

ConductScience Library. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. Papers, record 405385. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/405385

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol.
PubMed
Journal
J Biol Chem
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
779
iCite
Relative citation ratio, by iCite
21.1
iCite
Revised in PubMed
2022-03-17
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Abuchowski AA
2van Es TT
3Palczuk NCN C
4Davis FFF F

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Polyethylene GlycolsMajor topic
Serum Albumin, BovineMajor topic
Animals
Antibody Formation
Immunodiffusion
Molecular Weight
Rabbits

Source PubMed

Download CSV of topics

Cited by226

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 779 citations.

PMIDTitleJournalYearIn PapersSource
42877048Chemically modified gelatin derivatives: synthetic strategies, physicochemical properties, biodegradation, drug delivery and biomedical applications.Front Pharmacol2026https://conductscience.org/library/papers/42877048PubMed
42852286Impact of Organic Solvents, Surfactants, and Nonfunctionalized PEGs on PEGylation Reaction Yield.ACS Omega2026https://conductscience.org/library/papers/42852286PubMed
42734265Effective Reduction of Anti-PEG Antibody Recognition via PEG Copolymers with Ethyl Glycidyl Ether and Isopropyl Glycidyl Ether.Biomacromolecules2026https://conductscience.org/library/papers/42734265PubMed
42456079Suppressive Immune Response of Poly(sarcosine) Conjugated Proteins: PSARylation.Bioconjug Chem2026https://conductscience.org/library/papers/42456079PubMed
42438481Monodisperse PEG engineering for quantifiable surface conjugation on PLGA nanoparticles.Nanoscale Adv2026https://conductscience.org/library/papers/42438481PubMed
42272180Oxygen-Tolerant Photo-Induced Miniaturized Accelerated Atom Transfer Radical Polymerization (OPTIMA-ATRP) for High-Throughput Synthesis of Polymer Bioconjugates.Angew Chem Int Ed Engl2026https://conductscience.org/library/papers/42272180PubMed
41647359Regulatory framework for polymer-based nanotherapeutics in clinical translation.Front Bioeng Biotechnol2026https://conductscience.org/library/papers/41647359PubMed
41442576A Non-Antigenic Randomized Polyethylene Glycol/Poly(2-Phenyl-2-Oxazine)-Based Drug Delivery Platform.Macromol Rapid Commun2026https://conductscience.org/library/papers/41442576PubMed
41304777Comparative Stability of Synthetic and Natural Polymeric Micelles in Physiological Environments: Implications for Drug Delivery.Pharmaceutics2025https://conductscience.org/library/papers/41304777PubMed
41124269The evolution of nanomedicine: The rise of next-generation nanomaterials in cancer nanomedicine.Sci Adv2025https://conductscience.org/library/papers/41124269PubMed
41048377Optimising Monoclonal Antibody Drug Development for Inflammatory Bowel Disease.Clin Exp Gastroenterol2025https://conductscience.org/library/papers/41048377PubMed
40965131Distinct functions of cardiac β-adrenergic receptors in the T-tubule vs. outer surface membrane.Elife2025https://conductscience.org/library/papers/40965131PubMed
40857654Biofilm Eradication Using Water-Soluble Silver(I) Coumarin Complexes.Chembiochem2025https://conductscience.org/library/papers/40857654PubMed
40788220PD-L1-Targeting Biomimetic Photoresponsive Thermosensitive Liposomes for Triple-Negative Breast Cancer.Adv Sci (Weinh)2025https://conductscience.org/library/papers/40788220PubMed
40730517Considering the immunogenicity of PEG: strategies for overcoming issues with PEGylated nanomedicines.Nanomedicine (Lond)2025https://conductscience.org/library/papers/40730517PubMed
40476701pH Controlled Activation and Stabilization of Enzymes Using Responsive Polymer-Bioconjugates.Biomacromolecules2025https://conductscience.org/library/papers/40476701PubMed
40143042Clinical Applications of Targeted Nanomaterials.Pharmaceutics2025https://conductscience.org/library/papers/40143042PubMed
39990937Antigenicity Extension: A Novel Concept Explained by the Immunogenicity of PEG.ACS Bio Med Chem Au2025https://conductscience.org/library/papers/39990937PubMed
39860198Fibroin-Hybrid Systems: Current Advances in Biomedical Applications.Molecules2025https://conductscience.org/library/papers/39860198PubMed
39802382Advancing Therapeutic Strategies with Polymeric Drug Conjugates for Nucleic Acid Delivery and Treatment.Int J Nanomedicine2025https://conductscience.org/library/papers/39802382PubMed

See all 226 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/405385

GET https://conductscience.org/api/papers/v1/405385/cited_by?page=2